Evonik: Price increases for functional polymers for pharmaceutical applications

The Pharma Polymers business line, part of Evonik Röhm GmbH, a subsidiary of Evonik Industries AG, Essen, will implement price increases for its methyl methacrylate-based polymers for pharmaceutical applications by up to 12% for their global EUDRAGIT® business, effective January 1, 2011.

According to Evonik the company's priority is to enhance the quality and availability of supply and services. In this context significant investments were made to improve reliability, and to satisfy more stringent regulatory requirements. Additionally, increased wages and raw material costs are already above pre 2009 levels.

These investments is to further improve the company's infrastructure, strengthen business continuity and create competitive advantages for its pharmaceutical customers.